{"id":61112,"date":"2025-04-17T19:06:23","date_gmt":"2025-04-17T17:06:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/"},"modified":"2025-04-17T19:06:23","modified_gmt":"2025-04-17T17:06:23","slug":"claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/","title":{"rendered":"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy"},"content":{"rendered":"
\n

\nJigar S. Patel, MD, Named Chief Medical Officer<\/i>\n<\/p>\n

\nFernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer<\/i>\n<\/p>\n

MCLEAN, Va.–(BUSINESS WIRE)–$CTEV<\/a> #CTEV<\/a>–Claritev Corporation (\u201cClaritev\u201d or the \u201cCompany\u201d) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership team to support the company\u2019s strategic growth, transformation and mission to bring transparency to the healthcare ecosystem with innovative products and solutions.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nJigar S. Patel, MD, has been appointed Chief Medical Officer effective April 14, 2025. As a new member of the Executive Leadership Team, Patel will provide medical guidance on the strategic development and product innovation of Claritev\u2019s healthcare technology and network optimization solutions. Patel brings deep expertise in healthcare delivery, medical network dynamics and industry relationships. This experience will be integral as he works to align Claritev\u2019s products with the evolving needs of the industry, including health plans, payors and other medical organizations. Prior to joining Claritev, Patel spent more than 18 years at Cerner\/Oracle where he worked with large national healthcare companies on all aspects of their Healthcare Information Technology needs and strategy.\n<\/p>\n

\nFernando Schwartz, Ph.D., has been appointed Chief Artificial Intelligence Officer effective February 17, 2025. Schwartz leads the AI and Data Science Department on Chief Digital Officer Michael Kim\u2019s team. Bringing 15 years of leadership in data science and machine learning, Schwartz will lead the Company\u2019s AI and analytics strategy as well as new product development and capabilities that will benefit existing and new clients or partners. Prior to joining Claritev, Schwartz most recently served as the Vice President of AI at ADP. Before that, he led the global data science strategy for Merck\u2019s Human Health Division as the Associate Vice President and Global Head of Data Science.\n<\/p>\n

\n\u201cToday\u2019s announcement marks a pivotal moment in Claritev\u2019s strategic transformation journey,\u201d said Travis Dalton, Chairman, CEO and President of Claritev. \u201cWith their past industry experience and expertise, Jigar\u2019s and Fernando\u2019s roles will bring us a step closer to providing cutting-edge innovation and technology that promote more affordable, transparent and higher quality healthcare services.\n<\/p>\n

\nAbout Claritev<\/b>\n<\/p>\n

\nClaritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare. By developing purpose-build solutions that support all key stakeholders \u2013 including payors, employers, patients, providers, and third parties \u2013 Claritev is dedicated to making healthcare more accessible and affordable for all.\n<\/p>\n

\nClaritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Relations<\/b>
Pamela Walker
\n
VP, Marketing & Communication
\n
Claritev
\n
781-895-3118
\n
press@claritev.com<\/a><\/p>\n

Investor Relations<\/b>
Jason Wong
\n
SVP, Treasury & Investor Relations
\n
Claritev
\n
866-909-7427
\n
investor@claritev.com<\/a><\/p>\n

Shawna Gasik
\n
AVP, Investor Relations
\n
Claritev
\n
866-909-7427
\n
investor@claritev.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Jigar S. Patel, MD, Named Chief Medical Officer Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer MCLEAN, Va.–(BUSINESS WIRE)–$CTEV #CTEV–Claritev Corporation (\u201cClaritev\u201d or the \u201cCompany\u201d) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61112","6":"format-standard","7":"category-industry"},"yoast_head":"\nClaritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Jigar S. Patel, MD, Named Chief Medical Officer Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer MCLEAN, Va.–(BUSINESS WIRE)–$CTEV #CTEV–Claritev Corporation (\u201cClaritev\u201d or the \u201cCompany\u201d) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T17:06:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250417495531\/en\/2383479\/22\/Claritev-logo-Primary.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy\",\"datePublished\":\"2025-04-17T17:06:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/\"},\"wordCount\":547,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250417495531\\\/en\\\/2383479\\\/22\\\/Claritev-logo-Primary.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/\",\"name\":\"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250417495531\\\/en\\\/2383479\\\/22\\\/Claritev-logo-Primary.jpg\",\"datePublished\":\"2025-04-17T17:06:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250417495531\\\/en\\\/2383479\\\/22\\\/Claritev-logo-Primary.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250417495531\\\/en\\\/2383479\\\/22\\\/Claritev-logo-Primary.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/","og_locale":"en_US","og_type":"article","og_title":"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Pharma Trend","og_description":"Jigar S. Patel, MD, Named Chief Medical Officer Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer MCLEAN, Va.–(BUSINESS WIRE)–$CTEV #CTEV–Claritev Corporation (\u201cClaritev\u201d or the \u201cCompany\u201d) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/","og_site_name":"Pharma Trend","article_published_time":"2025-04-17T17:06:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250417495531\/en\/2383479\/22\/Claritev-logo-Primary.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy","datePublished":"2025-04-17T17:06:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/"},"wordCount":547,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250417495531\/en\/2383479\/22\/Claritev-logo-Primary.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/","url":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/","name":"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250417495531\/en\/2383479\/22\/Claritev-logo-Primary.jpg","datePublished":"2025-04-17T17:06:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250417495531\/en\/2383479\/22\/Claritev-logo-Primary.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250417495531\/en\/2383479\/22\/Claritev-logo-Primary.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/claritev-further-strengthens-leadership-team-as-part-of-business-transformation-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61112"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61112\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}